FDA Proposes Adverse Side-Effect Warnings Outside Convenience-Size OTCs
This article was originally published in The Tan Sheet
Executive Summary
Exterior labels on convenience-size packages of OTC drugs should include warnings about potential adverse side effects for people with some pre-existing conditions, according to an FDA proposed rule
You may also be interested in...
Convenience-Size Labeling Compliance Requires More Time, Money – Wyeth
FDA underestimates the time firms will need and the costs they will face to comply with the agency's proposed rule for convenience-size OTC drug facts labeling, according to Wyeth Consumer Healthcare
Convenience-Size Labeling Compliance Requires More Time, Money – Wyeth
FDA underestimates the time firms will need and the costs they will face to comply with the agency's proposed rule for convenience-size OTC drug facts labeling, according to Wyeth Consumer Healthcare
Convenience-Size Labeling Compliance Requires More Time, Money – Wyeth
FDA underestimates the time firms will need and the costs they will face to comply with the agency's proposed rule for convenience-size OTC drug facts labeling, according to Wyeth Consumer Healthcare